University of Auckland Receives $16 Million for Medical Research
奧克蘭大學獲一千六百萬美元醫學研究經費
更新於: 2026年6月15日 上午08:00
The University of Auckland stands at the forefront of medical innovation, consistently securing major funding to address global health challenges.
紐西蘭奧克蘭大學處於醫學創新的最前沿，持續獲得大額資金以應對全球健康挑戰。
A significant portion of this funding supports life-saving medical research.
這筆資金中有一大部分用於支持救命的醫學研究。
For instance, the Health Research Council of New Zealand has invested $16 million into intensive care studies over the last 15 years, resulting in annual health system savings of over $51 million.
例如，紐西蘭健康研究委員會在過去15年內向重症監護研究投入了1600萬美元，累計每年為健康系統節省超過5100萬美元。
Furthermore, in 2020, the university received more than $16 million from the Ministry of Business, Innovation and Employment to combat multi-drug resistant superbugs and assess environmental risks like erionite fibers.
此外，2020年，該大學獲得了商業、創新與就業部超過1600萬美元的撥款，用以對抗多重耐藥性超級細菌，並評估如纖維沸石等環境風險。
These research grants distinguish themselves from general university operating subsidies or private startup capital.
這些研究補助金與大學的一般營運補貼或私人創業資本截然不同。
By bridging the gap between academic research and commercial application through initiatives like UniServices, the University of Auckland transforms investment into public benefit.
通過像UniServices這類倡議，奧克蘭大學縮小了學術研究與商業應用之間的差距，將投資轉化為公共利益。
Whether developing new antibiotics or optimizing patient care, the university remains a vital hub for innovation, proving that medical research is a long-term investment that yields immense value for the health of society.
無論是開發新型抗生素還是優化患者護理，該大學始終是創新的重要樞紐，證明了醫學研究是一項能夠為社會健康帶來巨大價值的長期投資。
